Drawing for HFX ADAPTIVAI

USPTO serial 99895300

HFX ADAPTIVAI

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
ROTH, BENJAMIN H.
Law office
TMO LAW OFFICE 122

What this means

Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months. Monitor TSDR for the examiner's first action. No filing is required until an office action or other requirement is issued.

Status 638: Status 638 means your application has been assigned to a USPTO examining attorney who is reviewing it against federal law and existing marks. The first office action or approval usually follows within a few months.

Need help with HFX ADAPTIVAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bala Sundararajan

2560 General Armistead AvenueAudubon, PA 19403United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software application for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapy, based on input from the user; downloadable computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; recorded computer software application for use with a medical device for pain control to optimize and adjust electrical stimulation therapy; downloadable mobile applications for use with a medical device for pain control to program, optimize, and adjust electrical stimulation therapyACTIVE—
010Medical device, namely, an implantable electrical stimulation device for pain control; medical device, namely, a spinal cord stimulator for pain control; medical device for use in tissue and neural tissue for modulating neurological signals; electrical neuromodulation therapy device for pain control; implantable pulse generator for use with a medical device for pain control; implantable pulse generator for use with a spinal cord stimulator for pain control; implantable pulse generator and embedded computer software to optimize and adjust electrical stimulation therapy provided by a spinal cord stimulator; pulse generator for use with a medical device for pain control; pulse generator for use with a spinal cord stimulator for pain control; pulse generator and embedded computer software to program, optimize and adjust electrical stimulation therapy provided by a spinal cord stimulator; feature of a medical device that provides electrical stimulation therapy to a patient by way of leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device that provides electrical stimulation therapy to a patient by way of implantable leads, namely, therapy selection and optimization based on patient input by way of a smart phone or computing device; feature of a medical device for pain management that enables remote programming and optimization of electrical stimulation therapy via telemetry or wireless technology; medical device for pain management that enables remote programming, adjustment, and optimization of electrical stimulation therapyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 28, 2026DOCKASSIGNED TO EXAMINER—
Oct 26, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 25, 2026AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Jun 25, 2026PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jun 19, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 19, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance